|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 11630 Zenobia Court |
Address2 | |
City | Westminster |
State | CO |
Zip Code | 80031 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 315216-87
|
||||||||
|
6. House ID# 392100003
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Tanya Kelly-Bowry |
Date | 01/19/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3590: The Patient Protection and Affordable Care Act
*Worked to clarify language included in the Senate Amendment 3119 ensuring that public data sets remain open., Specifically, the Managers Package eliminated language that would change or delete the misuse of data definition and communicated that this definition was overly broad and needed to be clarified or removed entirely.
*Delivered a letter of endorsement for Senate Amendment 3119 regarding open data.
*Requested consideration to make the following data sets available:
vEncouraged Congress to ensure that public data streams, such as the Medicare Provider Analysis and Review (MEDPAR) remain available to private organizations such as HealthGrades.
vBroadening the data included in publicly available data sets is also encouraged. For example, making available for public analysis the inclusion of readmission rates and Medicare Advantage outcomes data would allow Health IT leaders to build more powerful decision making resources thus further empowering patients.
*Recommended that data currently available through CMS and other government entities continue to be available to public and private entities, and that additional data developed as a result of the following provisions, at a minimum, be equally accessible for the purposes of advancing the transparency of provider performance:
Provisions Related to Medicare Part B
1) Modification to Physician Quality Reporting Initiative (PQRI)
2) Requirement for Public Reporting by Hospitals and Ambulatory Surgical Centers on Health Care-Associated Infections
3) Require Ambulatory Surgical Centers (ASCs) to submit cost and other data
Provisions Related to Parts A and B
1) Reducing Potentially Preventable Hospital Readmissions
Provisions Related to Medicare Advantage Reform
1) Quality Bonus Payments. HEDIS, CAHPs, and other data
By coupling these new data elements with existing data streams, public/private partnerships will be enabled to enhance the information patients are seeking to help them make informed decisions with respect to quality and cost performance by providers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tanya |
Kelly-Bowry |
|
President |
|
David |
Sprenger |
|
Vice President |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 3962 - Affordable Health Care for America Act of 2009
*Provided the feedback as requested on the following sections of the legislation:
Sec. 1442 Development of New Quality Measures
As new quality measures are proposed and endorsed, and data is collected for tracking such measures, a provision should be inserted requiring the Secretary to make all data collected for these purposes publicly available to increase accountability and transparency.
Sec. 1444 Application of Quality Measures
As new quality measurement programs come on line, a provision should be inserted that requires the Secretary to make all data collected for measuring inpatient, outpatient, physician and renal dialysis services publicly available to increase accountability and transparency.
Recommend that data currently available through CMS and other government entities continue to be available to public and private entities, and that additional data developed as a result of any health care reform legislation, at a minimum, be equally accessible for the purposes of advancing the transparency of provider performance. This includes:
Sec 1461 and 1138A Public Reporting of Health Care Associated Infections
Sec. 1144 Ambulatory Surgical Center cost and quality data.
Sec. 1151 Any data collected to reduce potentially preventable hospital readmissions
Medicare Advantage data. Currently Medicare patient outcomes data sets do not include Medicare Advantage data. Opening this data set up for public reporting purposes will increase transparency in an effort to reduce cost and this data should be made publicly available.
Sec. 2402 Assistant Secy of Health Information
This section creates a HHS Assistant Secretary for Health Information charged with collection, reporting, and publishing of key health indicators, as well as ensuring the sharing of relevant information between federal departments, and the development of standards for the collection of health data.
Recommend that this person should also have responsibility for providing data to public and private organizations for the purpose of transferring knowledge, increasing transparency and accountability, and improving quality.
Sec. 2561 National Medical Device Registry
Requires the Secretary to establish a public national medical device registry to facilitate analysis of post-market safety and outcomes data on certain implantable, life-sustaining, and other types of medical devices. This would link data from manufacturers with patient safety and outcomes data from other sources.
Recommend that data collected under this provision be made available to public and private entities for the purposes of increasing transparency and accountability, and improving quality.
*Requested consideration to make the following data sets available:
vEncouraged Congress to ensure that public data streams, such as the Medicare Provider Analysis and Review (MEDPAR) remain available to private organizations such as HealthGrades.
vBroadening the data included in publicly available data sets is also encouraged. For example, making available for public analysis the inclusion of readmission rates and Medicare Advantage outcomes data would allow Health IT leaders to build more powerful decision making resources thus further empowering patients.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tanya |
Kelly-Bowry |
|
President |
|
David |
Sprenger |
|
Vice President |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |